Literature DB >> 21412501

Vitamin D deficiency in cirrhosis relates to liver dysfunction rather than aetiology.

Mikkel Malham1, Søren Peter Jørgensen, Peter Ott, Jørgen Agnholt, Hendrik Vilstrup, Mette Borre, Jens F Dahlerup.   

Abstract

AIM: To examine the vitamin D status in patients with alcoholic cirrhosis compared to those with primary biliary cirrhosis.
METHODS: Our retrospective case series comprised 89 patients with alcoholic cirrhosis and 34 patients with primary biliary cirrhosis who visited our outpatient clinic in 2005 and underwent a serum vitamin D status assessment.
RESULTS: Among the patients with alcoholic cirrhosis, 85% had serum vitamin D levels below 50 nmol/L and 55% had levels below 25 nmol/L, as compared to 60% and 16% of the patients with primary biliary cirrhosis, respectively (P < 0.001). In both groups, serum vitamin D levels decreased with increasing liver disease severity, as determined by the Child-Pugh score.
CONCLUSION: Vitamin D deficiency in cirrhosis relates to liver dysfunction rather than aetiology, with lower levels of vitamin D in alcoholic cirrhosis than in primary biliary cirrhosis.

Entities:  

Keywords:  Alcoholic liver cirrhosis; Child-Pugh score; Primary biliary cirrhosis; Vitamin D deficiency

Mesh:

Substances:

Year:  2011        PMID: 21412501      PMCID: PMC3051142          DOI: 10.3748/wjg.v17.i7.922

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  13 in total

Review 1.  Which circulating level of 25-hydroxyvitamin D is appropriate?

Authors:  Paul Lips
Journal:  J Steroid Biochem Mol Biol       Date:  2004-05       Impact factor: 4.292

2.  Routine isotope-dilution liquid chromatography-tandem mass spectrometry assay for simultaneous measurement of the 25-hydroxy metabolites of vitamins D2 and D3.

Authors:  Zoë Maunsell; Dennis J Wright; Sandra J Rainbow
Journal:  Clin Chem       Date:  2005-07-14       Impact factor: 8.327

3.  Hypovitaminosis D myopathy without biochemical signs of osteomalacic bone involvement.

Authors:  H Glerup; K Mikkelsen; L Poulsen; E Hass; S Overbeck; H Andersen; P Charles; E F Eriksen
Journal:  Calcif Tissue Int       Date:  2000-06       Impact factor: 4.333

4.  Patients with acute on chronic liver failure display "sepsis-like" immune paralysis.

Authors:  Hermann E Wasmuth; Dagmar Kunz; Eray Yagmur; Annette Timmer-Stranghöner; Daniel Vidacek; Elmar Siewert; Jens Bach; Andreas Geier; Edmund A Purucker; Axel M Gressner; Siegfried Matern; Frank Lammert
Journal:  J Hepatol       Date:  2005-02       Impact factor: 25.083

5.  Increased rate of bone loss at the femoral neck in patients with chronic liver disease.

Authors:  Sif Ormarsdóttir; Osten Ljunggren; Hans Mallmin; Karl Michaëlsson; Lars Lööf
Journal:  Eur J Gastroenterol Hepatol       Date:  2002-01       Impact factor: 2.566

Review 6.  Vitamin D replacement for cirrhosis-related bone disease.

Authors:  Bronwyn A Crawford; Eternity D Labio; Simone I Strasser; Geoffrey W McCaughan
Journal:  Nat Clin Pract Gastroenterol Hepatol       Date:  2006-12

7.  The heterogeneity of bone disease in cirrhosis: a multivariate analysis.

Authors:  Bronwyn A L Crawford; C Kam; A J Donaghy; G W McCaughan
Journal:  Osteoporos Int       Date:  2003-09-19       Impact factor: 4.507

8.  Bone disease in primary biliary cirrhosis: reversal of osteomalacia with oral 25-hydroxyvitamin D.

Authors:  J S Reed; S C Meredith; B A Nemchausky; I H Rosenberg; J L Boyer
Journal:  Gastroenterology       Date:  1980-03       Impact factor: 22.682

Review 9.  Vitamin D status in gastrointestinal and liver disease.

Authors:  Helen M Pappa; Elana Bern; Daniel Kamin; Richard J Grand
Journal:  Curr Opin Gastroenterol       Date:  2008-03       Impact factor: 3.287

10.  Risk of liver and other types of cancer in patients with cirrhosis: a nationwide cohort study in Denmark.

Authors:  H T Sorensen; S Friis; J H Olsen; A M Thulstrup; L Mellemkjaer; M Linet; D Trichopoulos; H Vilstrup; J Olsen
Journal:  Hepatology       Date:  1998-10       Impact factor: 17.425

View more
  44 in total

1.  1, 25(OH)₂D₃ inhibits hepatocellular carcinoma development through reducing secretion of inflammatory cytokines from immunocytes.

Authors:  Jian Guo; Zhenhua Ma; Qingyong Ma; Zheng Wu; Ping Fan; Xiaojie Zhou; Lulu Chen; Shuang Zhou; David Goltzman; Dengshun Miao; Erxi Wu
Journal:  Curr Med Chem       Date:  2013       Impact factor: 4.530

Review 2.  Resurgence of vitamin D: Old wine in new bottle.

Authors:  Raju Vaishya; Vipul Vijay; Amit Kumar Agarwal; Jabed Jahangir
Journal:  J Clin Orthop Trauma       Date:  2015-03-26

Review 3.  Reprint of: Nutrition in the Management of Cirrhosis and its Neurological Complications.

Authors:  Chantal Bémeur; Roger F Butterworth
Journal:  J Clin Exp Hepatol       Date:  2015-02-19

4.  Total 25(OH) vitamin D, free 25(OH) vitamin D and markers of bone turnover in cirrhotics with and without synthetic dysfunction.

Authors:  Jennifer C Lai; Daniel D Bikle; Blanca Lizaola; Hilary Hayssen; Norah A Terrault; Janice B Schwartz
Journal:  Liver Int       Date:  2015-03-27       Impact factor: 5.828

5.  Hepatobiliary quiz 11 (2014).

Authors:  Swastik Agrawal; Radha K Dhiman
Journal:  J Clin Exp Hepatol       Date:  2014-09

Review 6.  Bone health and vitamin D status in alcoholic liver disease.

Authors:  M Kizilgul; O Ozcelik; T Delibasi
Journal:  Indian J Gastroenterol       Date:  2016-06-01

7.  High prevalence of vitamin A deficiency and vitamin D deficiency in patients evaluated for liver transplantation.

Authors:  Mukund Venu; Eric Martin; Kia Saeian; Samer Gawrieh
Journal:  Liver Transpl       Date:  2013-04-15       Impact factor: 5.799

Review 8.  Alcohol: A Simple Nutrient with Complex Actions on Bone in the Adult Skeleton.

Authors:  Gino W Gaddini; Russell T Turner; Kathleen A Grant; Urszula T Iwaniec
Journal:  Alcohol Clin Exp Res       Date:  2016-03-12       Impact factor: 3.455

9.  Post-surgery cholecystectomy, hepatectomy, and pancreatectomy patients increase the risk of osteoporotic vertebral fracture.

Authors:  Wei-Zen Cheng; Yun-Lan Lin; Yuan-Chih Su; Mei-Chen Lin; Chang-Hsing Tseng; Ruey-Mo Lin; Sheng-Teng Huang
Journal:  J Bone Miner Metab       Date:  2020-08-05       Impact factor: 2.626

10.  Single-nucleotide polymorphism at CYP27B1-1260, but not VDR Taq I, is possibly associated with persistent hepatitis B virus infection.

Authors:  Qianqian Zhu; Na Li; Qunying Han; Zhu Li; Guoyu Zhang; Fang Li; Pingping Zhang; Jinghong Chen; Yi Lv; Zhengwen Liu
Journal:  Genet Test Mol Biomarkers       Date:  2012-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.